What are the potential therapeutic applications for Mesoblast’s technology?
Initially Mesoblast is developing adult stem cell products for degeneration of the cardiovascular and central nervous systems, degenerative disc disease, cartilage regeneration, diabetes, bone defects, eye diseases and for bone marrow transplantation in cancer patients. These are markets with inadequate or absent therapies.